Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients; ; et al in Diabetologia (2010), 53 AIMS/HYPOTHESIS: The aim of the study was to investigate the use of hyperglycaemic clamp tests to identify individuals who will develop diabetes among insulinoma-associated protein-2 antibody (IA-2A ... [more ▼] AIMS/HYPOTHESIS: The aim of the study was to investigate the use of hyperglycaemic clamp tests to identify individuals who will develop diabetes among insulinoma-associated protein-2 antibody (IA-2A)-positive first-degree relatives (IA-2A(+) FDRs) of type 1 diabetic patients. METHODS: Hyperglycaemic clamps were performed in 17 non-diabetic IA-2A(+) FDRs aged 14 to 33 years and in 21 matched healthy volunteers (HVs). Insulin and C-peptide responses were measured during the first (5-10 min) and second (120-150 min) release phase, and after glucagon injection (150-160 min). Clamp-induced C-peptide release was compared with C-peptide release during OGTT. RESULTS: Seven (41%) FDRs developed diabetes 3-63 months after their initial clamp test. In all phases they had lower C-peptide responses than non-progressors (p < 0.05) and HVs (p < 0.002). All five FDRs with low first-phase release also had low second-phase release and developed diabetes 3-21 months later. Two of seven FDRs with normal first-phase but low second-phase release developed diabetes after 34 and 63 months, respectively. None of the five FDRs with normal C-peptide responses in all test phases has developed diabetes so far (follow-up 56 to 99 months). OGTT-induced C-peptide release also tended to be lower in progressors than in non-progressors or HVs, but there was less overlap in results between progressors and the other groups using the clamp. CONCLUSIONS/INTERPRETATION: Clamp-derived functional variables stratify risk of diabetes in IA-2A(+) FDRs and may more consistently identify progressors than OGTT-derived variables. A low first-phase C-peptide response specifically predicts impending diabetes while a low second-phase response may reflect an earlier disease stage [less ▲] Detailed reference viewed: 8 (2 ULg) Bluetongue virus in wild deer, Belgium, 2005-2008Linden, Annick ; Grégoire, Fabien ; et alin Emerging Infectious Diseases (2010), 16(5), 833-836 Detailed reference viewed: 35 (18 ULg) Bluetongue Virus Detection By Real-Time Rt-Pcr In Culicoides Captured During The 2006 Epizootic In Belgium And Development Of An Internal Control; ; et al in Transboundary and Emerging Diseases (2009), 56(5), 170-177 Detailed reference viewed: 14 (0 ULg) Infection expérimentale de veaux par le virus de la fièvre catarrhale ovine de sérotype 8Dal Pozzo, Fabiana ; ; Guyot, Hugues et alin Epidémiologie et Santé Animale (2009), 55 Detailed reference viewed: 25 (7 ULg) Bluetongue virus antibodies in wild red deer in southern BelgiumLinden, Annick ; ; Grégoire, Fabien et alin Veterinary Record : Journal of the British Veterinary Association (2008) Detailed reference viewed: 13 (2 ULg) |
||